{"nct_id":"NCT06846281","title":"Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2025-07-23","start_date_type":"ACTUAL","primary_completion_date":"2030-02-07","primary_completion_date_type":"ESTIMATED","completion_date":"2032-01-08","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}